Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-04

Clinical Trial Update: Efficiency of Use of Baracetinib in Treatment of Lupus Nephritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Baracetinib in lupus nephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Baracetinib

Snippet

Sponsor: Assiut University | Conditions: Lupus Nephritis | Phase 3 | Status: UNKNOWN